This phenomenon is of particular concern, as elevated levels of Gal-9 in CLL patients have been positively correlated with advanced disease stages and are associated with poor prognostic outcomes [49,50]. This evidence concerns the gene LGALS9 and B-cell chronic lymphocytic leukemia.